“Although randomized clinical trials are normally used to approve therapeutics, the federal government has not required COVID ...

This year's headlines on COVID-19 featured new research on COVID-related mortality, post-acute sequelae of infection, vaccine ...

Aligos Therapeutics, Inc. ( (ALGS) ) has released its Q3 earnings. Here is a breakdown of the information Aligos Therapeutics, Inc. presented ...

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

Robert W. Baird analyst Brian Skorney maintained a Buy rating on Soleno Therapeutics (SLNO – Research Report) on November 6 and set a ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

A critical challenge during the early COVID-19 pandemic was determining whether a patient would survive the infection or die ...

Despite a dip in revenue, Arcturus Therapeutics Holdings Inc (ARCT) celebrates a successful vaccine launch in Japan and ...

Bashan declined to reveal how much the company owed creditors, but in its bankruptcy filing in U.S. Bankruptcy Court in ...

Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable diseaseColon ...

Good afternoon and welcome to Arcturus Therapeutics quarterly financial update and pipeline ... our self-amplifying mRNA COVID-19 vaccine. We're thrilled about our recent commercial launch of KOSTAIVE ...